Development, validation and initial evaluation of patient-decision aid (SUI-PDA©) for women considering stress urinary incontinence surgery by Ong, Hui Ling et al.
ORIGINAL ARTICLE
Development, validation and initial evaluation of patient-decision
aid (SUI-PDA©) for women considering stress urinary
incontinence surgery
Hui Ling Ong1 & Inna Sokolova2 & Holly Bekarma3 & Claire Curtis4 & Alastair Macdonald5 & Wael Agur1,2 & on behalf of
NHS Ayrshire & Arran Continence Multidisciplinary Team
Received: 14 May 2019 /Accepted: 8 July 2019
# The Author(s) 2019
Abstract
Introduction and hypothesis Following the design, face validation and publication of a novel PDA for women considering SUI
surgery, the main objective of the study is to evaluate the usefulness of SUI-PDA© by using a validated tool to obtain patient
feedback.
Methods From July 2018 toMarch 2019, the PDA, already incorporated into the patient care pathway, was objectively evaluated
using the Decisional Conflict Scale (DCS) to determine patients’ views. Patients recorded their values and reasons for requests
and declines of treatment. The total DCS score, scores from each DCS subgroup and individual patient responses were calculated
and analysed.
Results The mean age of the first 20 patients to complete the DCSwas 54 years, the mean BMI was 30.1 and the median parity was
3. The average total DCS score was only 9.29 out of 100 (range 0–29.69) suggesting that the PDAwas quite useful for patients
considering SUI surgery. Overall, the PDA had largely favourable responses across all five DCS subgroups. The ‘informed’
subgroup had the best score (6.67) while the ‘uncertainty’ subgroup had the least favourable score (14.58). Despite the procedure
pause, the mesh tape option remained on the PDA; however, no patient had chosen this option, with a large proportion citing ‘safety’
issues as the main reason. Bulking agent injections were the most popular choice (40.0%) and the most commonly performed
procedures (50.0%) mainly because of quicker ‘recovery’. The second most popular participant choice was colposuspension
(35.0%) followed by autologous fascial sling (25.0%), with women citing ‘efficacy’ as the main reason behind their choice.
Conclusion SUI-PDA© was reported by patients and clinicians to be useful with clinical decision-making for SUI surgery.
Further validation in a larger patient group is underway.
Keywords Decisional conflict scale . Patient decision aid . Stress urinary incontinence . Surgery
Introduction
SUI is the loss of urine when coughing, laughing, sneezing or
exercising. It is a common and distressing condition, with
negative impact on quality of life. The prevalence varies from
20 to 50% and is associated with age and parity [1]. If conser-
vative treatment, e.g. pelvic floor muscle training, is not suc-
cessful, the most successful surgical procedures are mid-
urethral mesh tape, colposuspension, autologous fascial sling
and urethral bulking agent injections. Women have a 10%
lifetime risk of requiring continence surgery [1].
Between April 2008 to March 2017, procedure data from
the UK NHS confirmed that 100,516 patients had a mid-
urethral tape procedure, while only 1195 patients had a non-
tape SUI procedure [2]. Although the 2013 national guideline
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from The National Institute for Health and Care Excellence
(NICE) recommended that tape and non-tape SUI procedures
be offered equally [3], 84 mesh tape procedures were per-
formed for every 1 non-tape procedure over the 10-year period
[2]. Hundreds of patients recently engaged in litigation on the
basis of lack of informed consent, particularly in offering al-
ternatives to the mesh tape option. In July 2018, the safety
concerns led to a pause in the use of vaginal mesh in The
British Isles and prompted an increasing desire to explore
the non-mesh alternatives.
Little is known, however, about how patients choose
among different treatment options for SUI [4] and there are
no validated patient decision aids (PDAs) in this context.
PDAs have been shown to increase patient knowledge,
clarity about their own values and accuracy of risk perceptions
regarding various management options [5]. Women consider-
ing SUI surgery require up-to-date information on all common
and available surgical procedures as well as support in their
decision-making, tailored to their values and needs.
Our team designed and developed a novel SUI surgery
patient decision aid (SUI-PDA) to help women in making a
choice of treatment based on their own individual values. This
study reports the development and validation of SUI-PDA as
well as the initial evaluation of its usefulness in clinical prac-
tice for women considering SUI surgery.
Methods and materials
The Methods and Results section follows the SUNDAE
Statement (Standards for UNiversal reporting of patient
Decision Aid Evaluation studies) [6] of conducting and
reporting studies evaluating PDAs in clinical settings
(Fig. 1).
Face validation
The ‘literature review’ stream of the relevant Scottish
Government Independent Group, published in 2015 [7], pro-
vided the scientific evidence base upon which the information
within SUI-PDA©were populated and represented. The early
design followed the broad lines of the ‘What Matters to You’
Initiative [8] of NHS Scotland to encourage patients to explore
their own values before making their decision. The first ver-
sion was drafted and face-validated by members of NHS
Ayrshire & Arran Continence Multi-Disciplinary Team
(MDT), including urogynaecologists, urologists, physiothera-
pists, continence specialist nurses and a clinical librarian. The
PDAwas later reviewed by members of the relevant Scottish
Government Expert Group including expert patient represen-
tatives (who had good outcomes and those who had adverse
outcomes of continence surgery), an improvement adviser
from the NHS Scotland Person-Centred Department and an
academic in design from Glasgow School of Art.
Concomitantly, face validation continued with service users,
the procedure-naïve patients considering SUI surgery. The
comments were fed back to the core development team and
eight versions of the four components of the PDA were pro-
duced following team discussions—including two meetings
in person as well as group email communications. Plain
English guidelines were followed to produce clear and concise
patient information to communicate complex medical termi-
nology in a language that is easy to understand. The final
version of the SUI-PDAwas published on the NHS Ayrshire
& Arran website [8] on 3 November 2017.
Components of SUI-PDA
The SUI-PDA is a purpose-built, decision-support booklet
structured to guide the patient through a sequence of four
components: What Matters To Me , Care Pathway,
Procedure Comparison and Request-for-Treatment. The
‘What Matters To Me’ component (Fig. 2) clarifies patients’
own values and is comprised of 13 aspects of clinical care that
may matter to women considering SUI surgery, e.g. ‘Avoid
major abdominal surgery’ and ‘Quicker recovery…’.
Patients were asked to rate every aspect on a 11-point visual
analogue scale (VAS) and select the three most important to
them. A free text box was provided to capture any other aspect
of care, unique to the individual. The ‘Care Pathway’ [Fig. 3]
reminds the patients of the various non-surgical treatment op-
tions, highlights their position on the pathway and justifies the
need for surgery at the point of decision-making.
The ‘Procedure Comparison’ component (Fig. 4) summa-
rises the information on the four main surgical treatment op-
tions (mesh tape, colposuspension, autologous sling and
bulking agent injection) into tables. The main risks and bene-
fits of each treatment option are clearly outlined to ensure that
patients can visually compare the differences. The develop-
ment team has reached consensus on the main advantages and
disadvantages following the literature review [9–13]. Due to
the wide variation in the risk incidences reported in the liter-
ature for the four procedures, the group decided not to include
any specific figures on adverse events. This approach is con-
sistent with the one taken by the various UK groups develop-
ing national patient information leaflets [14]. The comparison
table also provided information on what happens if each sur-
gical option does not work in controlling urine leakage. The
last component, ‘Request for Treatment’ (Fig. 5), is interactive
as the patient requests one of the four procedures and provides
reason(s). This component also asks for reasons behind de-
clining the other three options. The reasons behind the re-
quests for and declines of treatment options were categorised
into four themes: ‘efficacy’, ‘safety’, ‘invasiveness’ and
‘recovery’.
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Delivery of the SUI-PDA
All women had completed a conservative treatment pro-
gramme, had urodynamics-proven SUI and were considering
SUI surgery in either the Urology or Gynaecology
Department. SUI-PDA is not a stand-alone tool, but is rather
the final stage of decision-making after patients have read the
updated national leaflets for the four SUI procedures pub-
lished by The Scottish Government, The British Association
of Urological Surgeons (BAUS) and The British Society of
Urogynaecology (BSUG).
The SUI-PDA was delivered to all patients by the
specialist nurses who performed their urodynamics stud-
ies. The sample was sequential, not random, as all
women spoke English as first language and completing
the PDA is an essential criterion before discussion at
the MDT meeting and subsequent surgery. Therefore,
all women were asked to complete the SUI-PDA prior
to being informed of availability of individual options.
While the two hospitals had followed the mesh pause,
the synthetic mid-urethral tape procedure remained as
one of the options on the PDA—with a clear plan for
external referral if a woman requested it. At the point of
making a choice of which SUI procedure to go for, and
before consultations with the surgeons, patients were
asked to read and complete the SUI-PDA. Patients were
specifically asked to (1) indicate their three most impor-
tant values using a visual analogue scale (0 = not impor-
tant, 10 = most important), (2) request only one surgical
procedure to undergo, (3) provide their own reason(s)
behind their choice and (4) evaluate the usefulness of
the PDA by completing the Decisional Conflict Scale
(DCS). The completed SUI-PDA was filed in patient
records prior to consultation with the surgeon.
Subsequently, the Continence Multi-Disciplinary Team
(MDT) reviewed individual patient’s clinical condition,
previous interventions, individual values and procedure
choice on the SUI-PDA before a group clinical decision
was made.
Responses collected from SUI-PDAs and DCSs were
anonymised and data were entered into a secure database prior
to statistical analysis. All calculations were made using SPSS
Statistics (version 23). The evaluation project did not require
research ethics approval. The confirmatory letter from the
Research and Development department, NHS Ayrshire and
Arran, is in Appendix B.
Results
The delivery of SUI-PDA to women considering SUI
surgery in the two hospitals of our Health Board,
Fig. 1 SUI-PDA development flowchart
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University Hospital Crosshouse and University Hospital
Ayr, had high fidelity. The SUI-PDA has been incorpo-
rated into the continence care pathway (Fig. 3) and its
completion had become an essential component of the
paperwork and a requirement prior to MDT discussion.
Although 'doing nothing' was an available option on the
pathway, all women who completed the PDA decided to
go ahead with surgery. At the time of writing, 40 wom-
en have completed the PDA and 20 have completed the
evaluation using the DCS.
Impact on service
The use of SUI-PDA has significantly impacted the ser-
vice and the pattern of continence surgery in our hospi-
tal. One example of positive influence is our respon-
siveness to patient choice by re-introducing the autolo-
gous fascial sling procedure in our hospital in spring
2016 [15]. However, one patient expressed negative
hindsight by stating her wish that this PDA had been
available prior to her first continence surgery. She be-
lieved that had she been given the choice among the
four procedures, she would not have agreed to undergo
the one that had left her with long-term complications.
Usefulness in patient choice and decision-making
From July 2018 to March 2019, this evaluation project
collected data for the first group of women who com-
pleted the SUI-PDA and the Decisional Conflict Scale
(DCS). The DCS (Appendix A) is the validated and the
most commonly used tool in evaluating the usefulness
of PDAs to patients [16]. It comprises a 16-item state-
ment format, categorised into 5 subgroups (uncertainty,
informed, values clarity, support and effective) with 5
response category statements (strongly agree, agree, nei-
ther agree nor disagree, disagree and strongly
disagree). A total score was calculated per patient as
well as the individual score for each of the five sub-
groups. A total score of 0 means ‘no decisional conflict’
and a score of 100 means ‘extremely high decisional
conflict’.
Forty women have completed the PDA since the start
date in September 2016, and 20 women completed both
the PDA and DCS from July 2018 to March 2019. The
average age for those who completed both SUI-PDA
and DCS was 54 years, the average BMI was 30.1
and the median parity was 3. All women were white
Caucasian and English was their first language.
Fig. 2 ‘What matters to me’
component of SUI-PDA
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Table 1 shows the frequency of requests and declines for
treatment. Bulking agent injections were the most common
choice of procedure (8/20, 40%), and their most common ac-
ceptance theme was ‘recovery’, followed by colposuspension
(7/20, 35.0%) and autologous sling (5/20, 25%). Although the
option of using the mesh remained on the PDA, no patient had
chosen this option. The most common reason for decline
conformed to the theme ‘safety’. It was difficult to unpack a
true understanding of the mesh-related adverse events men-
tioned in the PDA from the effect of the negative stories in
the media. However, seven women mentioned the ‘media’
attention in their stated reason behind declining the mesh tape
option. Three women declined the mesh option as being ‘too
invasive’, ‘invasive and risky’ and ‘big operation’. Surgical
choice did not appear to be influenced by age, BMI or parity.
Table 2 shows that cure from leakage, avoiding repeat surgery
and quick recovery, were the top three values/concerns indi-
cated by patients. Table 3 relates the procedure performed to
the corresponding top three values/concerns indicated by
patients.
Fig. 3 ‘Treatment pathway’
component of SUI-PDA
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The total DCS score was 9.29 (range 0.0 – 29.69), suggesting
an overall usefulness of the SUI-PDA to women considering
surgery (Table 4). Women found the Information domain to be
the most helpful (6.67), whereas the relatively higher score for
Uncertainty (14.58) suggests that, despite using the SUI-PDA,
some women still lacked full confidence in their choices.
There was one instance of disagreement between patient
choice and MDT choice. The patient had requested a
colposuspension procedure but later agreed with the MDT
view to undergo, at least initially, the less invasive bulking
agent injection because of co-morbidities. However, her
individual total DCS score remained low at 4.89, suggesting
overall confidence and usefulness of the PDA to her original
decision-making.
Discussion
Principle statements
This is the first study in the scientific literature to report the
development, validation and initial evaluation of a patient
Fig. 4 ‘Procedure comparison’
component of SUI-PDA
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decision aid for women considering surgery for stress urinary
incontinence in a real-life clinical practice. The four-
component SUI-PDA worked as intended and appears to be
useful in assisting women considering SUI surgery by (1) clar-
ifying their values, (2) providing information on individual
procedure’s benefits and risks and (3) direct support and rea-
soning during the decision-making process.
The PDA provided valuable insight into how women make
surgery choices which mostly, but not always, were based on
their pre-expressed values. For example, it demonstrated how
Fig. 5 ‘Request for Treatment’
component of SUI-PDA
Table 1 Frequency of patients’ requests and declines for treatment
No. of request
for treatment (%)
Commonest
request theme
No. of decline
of treatment (%)
Commonest decline theme MDT Choice
no.(%)a
Mesh tape 0 (0.0) – 20 (100) Safety (n = 13, mesh complications) 0 (0)
Colposuspension 7 (35.0) Efficacy 13 (65.0) Recovery (n = 4) 5b (25.0
Autologous fascial sling 5 (25.0) Efficacy 15 (75.0) Safety (n = 10, self-catheterisation) 5 (25.0)
Bulking agent injections 8 (40.0) Recovery 12 (60.0) (Lack of) efficacy (n = 12) 10 (50.0)
a All performed procedures matched MDT choice
bOne patient had later agreed to undergo the procedure suggested by the MDT (bulking agent injection) rather than her original choice on the PDA
(colposuspension)
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the majority of women had prioritised safety over efficacy by
choosing to undergo a bulking agent procedure as their first
choice. This is consistent with what Robinson et al. had sug-
gested in “What do women want?” [4]. Another example was
the apparent difference in perception of ‘invasiveness’ between
clinicians and women. Although the tape procedures were de-
scribed in the literature as minimally invasive, three women
declined this option and indicated (on the Request-for-
Treatment section) a perception that the permanent mesh device
is ‘too invasive’, ‘invasive and risky’ and a ‘big operation’.
For the first time, our study suggests that our robustly de-
signed PDA is useful for women considering SUI surgery and
has the potential to achieve similar benefits shown by PDAs in
other clinical conditions [5]. The Cochrane systematic review
of a wide range of conditions has shown that PDAs decreased
decisional conflict related to patients feeling uninformed and
decreased the number of patients who were considered ‘pas-
sive’ in decision-making [5].
Relation to other literature
Although no studies in the literature validated a PDA for SUI
surgery, there was one attempt to explore the usefulness of a
purpose-designed PDA for prolapse surgery [17]. The pro-
lapse PDA, however, was not highly successful as the tool
was not validated and did not include a full exploration of
individual patient values.
Clinical implications
The concept of shared-decision-making using Patient
Decision Aids is relatively new in the urogynaecology and
female urology subspecialty. Although safety and efficacy
have been our primary outcomes for several decades, it is
perhaps time to consider shared decision-making as our third
outcome that is more likely to be achieved with the vast ma-
jority of patients [18].
While the 2015 Montgomery ruling [19] is believed by
many to have resulted in an increased consultation time for
women considering SUI surgery, our PDA has the potential
to focus the consultation time and provide the best value.
This potential is dependant on the point of introduction
into the continence care pathway. In our experience, the
best stage of administering the SUI-PDA was at the point
of confirming a diagnosis of urodynamic stress inconti-
nence (USI) and prior to discussion with the surgeons or
with other MDT members. More data on the cost-
effectiveness of using PDAs in general are required, as
the Cochrane review did not find that their use decreased
healthcare costs and, in some studies, there are in fact in-
creased healthcare costs.
Table 2 Frequency of selected top three values/concerns by patients
Value/concern No. of patients choosing
value in top 3 choice (%)
Cure from leakage 18 (90.0)
Avoid repeat surgery in the future 10 (50.0)
Quick recovery and return to
normal activities
7 (35.0)
Avoiding mesh complications 6 (30.0)
Avoiding self-catheterisation 6 (30.0)
Just using fewer pads 2 (10.0)
Undergoing day surgery 1 (5.0)
Avoid major abdominal surgery 1 (5.0)
Avoid future surgery for prolapse 3 (15.0)
Least pain after surgery 1 (5.0)
Avoid general anaesthesia 1 (5.0)
Table 3 Frequency of procedure performed and the corresponding top three values/concerns indicated by patients
Cure from leakage Avoid repeat surgery Quick recovery and quick
return to normal activities
Avoid self-catheterisation
Mesh 0 (0) 0 (0) 0 (0) 0 (0)
Colposuspension 7 (38.9) 4 (40.0) 3 (42.9) 3 (50.0)
Autologous fascial sling 5 (27.8) 3 (30.0) 1 (14.2) 1 (16.7)
Bulking agent injections 6 (33.3) 3 (30.0) 3 (42.9) 2 (33.3)
Table 4 Decisional Conflict Scale (DCS) scores
DCS subgroup (no. of patients) Mean scorea (SD) Range
Informed (n = 20) 6.67 (10.68) 0.00–33.33
Values (n = 19) 10.53 (10.70) 0.00–25.00
Support (n = 19) 7.89 (11.61) 0.00–33.33
Uncertainty (n = 20) 14.58 (18.71) 0.00–58.33
Effective (n = 19) 8.88 (13.23) 0.00–43.75
Overall DCS Score (n = 19) 9.29 (9.29) 0.00–29.69
a Score ranges from 0 to 100, zero (0) meaning no decisional conflict and
100 meaning strong confliction
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Strengths and limitations
Our study followed a robust face-validation process that in-
volved all relevant multidisciplinary stakeholders, including
patients, using the most robust 16-item evaluation tool, the
DCS, and the most comprehensive reporting according to
the SUNDAE statement. The SUI-PDA scored highly overall,
particularly in the Information domain. However, some wom-
en remained unsure about their choice, with the least
favourable score in the Uncertain domain.
Our initial evaluation reports on a relatively small number
of women considering SUI surgery. To ensure that our find-
ings are generalisable to a larger population, data collection is
still on-going to further validate the usefulness of SUI-PDA in
a larger group. As the SUI-PDA had already been incorporat-
ed into the continence care pathway, this study could not de-
tect any change in our patients’ decisional conflict before and
after introduction of the PDA.
While the mid-urethral tape option was not available in our
hospital, there were clear plans for onward referral if a patient
chose this option.We believe themediamay have influenced the
decision of some of our patients; however, the 2014 mesh pro-
cedures suspension in Scotland in itself may not have signifi-
cantly influenced the results of our PDA evaluation project con-
ducted in 2018-2019. Our results can only be applicable to white
Caucasian English-speaking women; however, the SUI-PDA is
available in other languages by request to our Health Board [8].
Further research
Further evaluation of the SUI-PDA is underway to consolidate
the above findings and to further explore the reasons behind
the relatively less favourable score in the Uncertain domain.
To measure a potential reduction in decisional conflict, a fu-
ture research project would include a prospective comparative
study, preferably randomised, between women who used the
PDA and those who engaged only in standard counselling,
provided ethical matters are fully considered. In addition, we
are also planning to relate the patient choice using SUI-PDA
to the outcome of surgery and to study postoperative patient
reflections.
Conclusion
The SUI-PDA was reported by patients and clinicians to be
useful with clinical decision-making for SUI surgery. Further
validation in a larger patient group is underway.
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